Logo image of MATH

METALPHA TECHNOLOGY HOLDING (MATH) Stock Fundamental Analysis

NASDAQ:MATH - Nasdaq - KYG283651076 - Common Stock - Currency: USD

3.64  +0.32 (+9.64%)

After market: 3.5259 -0.11 (-3.13%)

Fundamental Rating

3

Overall MATH gets a fundamental rating of 3 out of 10. We evaluated MATH against 53 industry peers in the Consumer Finance industry. While MATH is still in line with the averages on profitability rating, there are concerns on its financial health. While showing a medium growth rate, MATH is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

MATH had positive earnings in the past year.
In the past year MATH has reported a negative cash flow from operations.
In the past 5 years MATH always reported negative net income.
MATH had a negative operating cash flow in each of the past 5 years.
MATH Yearly Net Income VS EBIT VS OCF VS FCFMATH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

MATH has a better Return On Assets (3.56%) than 71.70% of its industry peers.
Looking at the Return On Equity, with a value of 36.93%, MATH belongs to the top of the industry, outperforming 98.11% of the companies in the same industry.
With an excellent Return On Invested Capital value of 32.37%, MATH belongs to the best of the industry, outperforming 96.23% of the companies in the same industry.
Industry RankSector Rank
ROA 3.56%
ROE 36.93%
ROIC 32.37%
ROA(3y)-32.7%
ROA(5y)-29.06%
ROE(3y)-124.62%
ROE(5y)-89.61%
ROIC(3y)N/A
ROIC(5y)N/A
MATH Yearly ROA, ROE, ROICMATH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

Looking at the Profit Margin, with a value of 19.82%, MATH belongs to the top of the industry, outperforming 84.91% of the companies in the same industry.
With an excellent Operating Margin value of 28.51%, MATH belongs to the best of the industry, outperforming 84.91% of the companies in the same industry.
With a Gross Margin value of 39.85%, MATH perfoms like the industry average, outperforming 43.40% of the companies in the same industry.
Industry RankSector Rank
OM 28.51%
PM (TTM) 19.82%
GM 39.85%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MATH Yearly Profit, Operating, Gross MarginsMATH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MATH is creating value.
The number of shares outstanding for MATH has been increased compared to 1 year ago.
MATH has more shares outstanding than it did 5 years ago.
MATH has a worse debt/assets ratio than last year.
MATH Yearly Shares OutstandingMATH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MATH Yearly Total Debt VS Total AssetsMATH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

MATH has an Altman-Z score of 0.78. This is a bad value and indicates that MATH is not financially healthy and even has some risk of bankruptcy.
MATH's Altman-Z score of 0.78 is in line compared to the rest of the industry. MATH outperforms 58.49% of its industry peers.
MATH has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.30, MATH belongs to the best of the industry, outperforming 81.13% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 0.78
ROIC/WACC3.6
WACC8.99%
MATH Yearly LT Debt VS Equity VS FCFMATH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M 15M

2.3 Liquidity

MATH has a Current Ratio of 1.11. This is a normal value and indicates that MATH is financially healthy and should not expect problems in meeting its short term obligations.
MATH has a Current ratio (1.11) which is in line with its industry peers.
MATH has a Quick Ratio of 1.11. This is a normal value and indicates that MATH is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.11, MATH is in line with its industry, outperforming 50.94% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 1.11
MATH Yearly Current Assets VS Current LiabilitesMATH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

4

3. Growth

3.1 Past

MATH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 124.18%, which is quite impressive.
The Revenue has grown by 390.15% in the past year. This is a very strong growth!
MATH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 43.45% yearly.
EPS 1Y (TTM)124.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%235.35%
Revenue 1Y (TTM)390.15%
Revenue growth 3Y317.71%
Revenue growth 5Y43.45%
Sales Q2Q%287.81%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MATH Yearly Revenue VS EstimatesMATH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 22.75, which indicates a rather expensive current valuation of MATH.
Compared to the rest of the industry, the Price/Earnings ratio of MATH indicates a slightly more expensive valuation: MATH is more expensive than 66.04% of the companies listed in the same industry.
MATH is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.46, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 22.75
Fwd PE N/A
MATH Price Earnings VS Forward Price EarningsMATH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

86.79% of the companies in the same industry are more expensive than MATH, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.99
MATH Per share dataMATH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for MATH!.
Industry RankSector Rank
Dividend Yield N/A

METALPHA TECHNOLOGY HOLDING

NASDAQ:MATH (7/21/2025, 8:17:38 PM)

After market: 3.5259 -0.11 (-3.13%)

3.64

+0.32 (+9.64%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryConsumer Finance
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners10.91%
Inst Owner ChangeN/A
Ins Owners11.31%
Ins Owner ChangeN/A
Market Cap139.67M
AnalystsN/A
Price TargetN/A
Short Float %0.22%
Short Ratio0.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 22.75
Fwd PE N/A
P/S 4.45
P/FCF N/A
P/OCF N/A
P/B 8.29
P/tB 8.29
EV/EBITDA 3.99
EPS(TTM)0.16
EY4.4%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.74
FCFYN/A
OCF(TTM)-0.74
OCFYN/A
SpS0.82
BVpS0.44
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.56%
ROE 36.93%
ROCE 53.13%
ROIC 32.37%
ROICexc N/A
ROICexgc N/A
OM 28.51%
PM (TTM) 19.82%
GM 39.85%
FCFM N/A
ROA(3y)-32.7%
ROA(5y)-29.06%
ROE(3y)-124.62%
ROE(5y)-89.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA 0.55
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 1.11
Altman-Z 0.78
F-Score5
WACC8.99%
ROIC/WACC3.6
Cap/Depr(3y)162.67%
Cap/Depr(5y)97.6%
Cap/Sales(3y)4.5%
Cap/Sales(5y)2.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)124.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%235.35%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)390.15%
Revenue growth 3Y317.71%
Revenue growth 5Y43.45%
Sales Q2Q%287.81%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y823.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1597.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1628.51%
OCF growth 3YN/A
OCF growth 5YN/A